Recent Multiple Sclerosis (MS) Research for November 2024
Beta Interferon
Topics: Research & Development, Multiple Sclerosis (MS)
Regions: Global
| Multiple Sclerosis Therapeutics
Topics: Multiple Sclerosis (MS), Research & Development, Drug Discovery
Regions: Global
| Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Multiple Sclerosis (MS), Drug Discovery
| Global Autoinjectors Market (4th Edition), 2021-2035 Distribution by Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Th
Topics: Antibody Technologies, Pain, Arthritis, Diabetes, Multiple Sclerosis (MS), Needles, Syringes, IV Access, CNS/Neurology, Rheumatology/Arthritis
Regions: Asia, Europe, North America, Oceania, Global
| Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Topics: Multiple Sclerosis (MS), Clinical Trial
| Multiple Sclerosis Market in US 2022-2026
Topics: Multiple Sclerosis (MS), Research & Development
Regions: United States
| Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021
Topics: Multiple Sclerosis (MS), Research & Development, Prescription Drugs, Drug Discovery, CNS/Neurology
| Global Multiple Sclerosis (MS) Market – Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country (2021 Edition): Market Insights, Pipeline and Forecast with Impact of COVID-19 (2021-2026)
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Drug Discovery
Regions: Global
| Global Specialty Generics Market Size study, by Type (Injectables, Oral Drugs, Others), By Application (Oncology, Inflammatory Conditions, Hepatitis C, Multiple Sclerosis, Others) by End-use (, Retail, Hospital, Others) and Regional Forecasts 2022-2028
Topics: Hepatitis, Multiple Sclerosis (MS), Generics Drugs, Manufacturing, Packaging & Detailing, Research & Development
Regions: Global
| Global Neurological Biomarkers Market Size study, by Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism Spectrum Disorder, Others), By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By End-use (Hospital & Hospital Laboratories, In
Topics: Genomics, Proteomics, Biomarkers, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), CNS/Neurology, Behavioral Health
Regions: Global
| Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Dried Form and Extract Form), Application (Pain Management, Tourette Syndrome, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer,
Topics: Pain, Alzheimer's Disease, Cancer Treatment, Mental Health, Multiple Sclerosis (MS), COVID-19/Coronavirus, Alternative & Complementary Medicine, General Pharmaceuticals, Pharmacy & Distribution, Research & Development, Drug Stores, Behavioral Health
Regions: Global
| Prefilled Syringes Market by Material (Glass-based and Plastic-based), Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), Therapeutic (Large Molecules and Small Molecules), and Application (Anap
Topics: Diabetes, Multiple Sclerosis (MS), Needles, Syringes, IV Access, Rheumatology/Arthritis
Regions: Global
| Targeted Therapeutics Market - By Type (Monoclonal Antibodies, Small Molecular Inhibitors, Prodrug, And Nano-Particulate Antibody Conjugates), By Application (Breast Cancer, Leukemia, Colorectal Cancer, Lymphoma, Renal Cancer, Multiple Sclerosis, Wet Age-
Topics: Antibody Technologies, Cancer Treatment, Multiple Sclerosis (MS), Pharmacy & Distribution, Drug Discovery, Drug Stores, Oncology/Hematology, Ophthalmology
Regions: Global
| Primary Progressive Multiple Sclerosis (PPMS) - Epidemiology Forecast to 2032
Topics: Multiple Sclerosis (MS)
| Secondary Progressive Multiple Sclerosis (SPMS) - Epidemiology Forecast to 2032
Topics: Multiple Sclerosis (MS)
| Walking impairment in Multiple sclerosis Market Insights, Competitive Landscape and Market Forecast–2026
Topics: Multiple Sclerosis (MS)
| Multiple Sclerosis - Epidemiology Forecast to 2032
Topics: Multiple Sclerosis (MS)
| Walking impairment in Multiple sclerosis Market Insights, Competitive Landscape and Market Forecast–2027
Topics: Multiple Sclerosis (MS)
| Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North Am
Topics: Research & Development, Arthritis, Diabetes, Autoimmune, Multiple Sclerosis (MS), COVID-19/Coronavirus, Drug Discovery, Rheumatology/Arthritis
Regions: Africa, Asia, Europe, Middle East, North America, Oceania, South America, Global
| Neurological Biomarkers Market, by Biomarker Type (Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, and Genomics Biomarkers), by Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Ot
Topics: Genomics, Proteomics, Biomarkers, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), Drug Discovery
| Central Nervous System Disorders Therapeutics Market, by Disease Type (Neurodegenerative Disorders {Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Others}, Infectious Diseases, Psychotic Disorders, Anxiety Disorders, Trauma, Mood Disord
Topics: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), Drug Discovery, Infectious Diseases, CNS/Neurology
| Central Nervous System Disorders Therapeutics Market, by Disease Type (Neurovascular Diseases, Trauma, Mental Health {Anxiety Disorders, Epilepsy, and Others}, Degenerative Diseases {Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, and Others
Topics: Alzheimer's Disease, Mental Health, Parkinson's Disease, Multiple Sclerosis (MS), Epilepsy, Hospitals & Clinics, Drug Discovery, CNS/Neurology
Regions: Asia, Middle East, North America, Oceania
| Autoinjectors Global Market Report 2022
Including: 1) By Type: Disposable Autoinjectors; Reusable Autoinjectors
2) By Therapy: Rheumatoid Arthritis; Multiple Sclerosis; Diabetes; Anaphylaxis; Other Therapies
3) By Route Of Administration: Subcutaneous; In
Topics: Arthritis, Diabetes, Multiple Sclerosis (MS), Diabetes
Regions: Global
| Medicinal Cannabis Market, by Point of Sale (Dispensaries, Online Pharmacy, Hospital Pharmacy), by Active Ingredient (Tetrahydrocannabinol (THC) and Cannabidiol (CBD)), and by Therapeutic Application (Pain, Arthritis, Neurological Disease (Epilepsy, Multi
Topics: Pain, Arthritis, Multiple Sclerosis (MS), Epilepsy, Alternative & Complementary Medicine, General Pharmaceuticals, Pharmacy & Distribution, Research & Development
Regions: Africa, Asia, Europe, Middle East, North America, Oceania
| Magnetoencephalography Devices Market, by Application (Clinical Application, (Dementia, Autism, Schizophrenia, Multiple Sclerosis, Stroke, Epilepsy, Traumatic Brain Injury, Brain Tumor), and Research Applications), by End User (Hospitals, Imaging Centers,
Topics: Multiple Sclerosis (MS), Epilepsy, Hospitals & Clinics, Cardiovascular, CNS/Neurology, Behavioral Health
| Specialty Generic Drugs Market Share, Size, Trends, Industry Analysis Report, By Application (Oncology, Infectious Diseases, Multiple Sclerosis, Hepatitis C); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2021 - 2028
Topics: Hepatitis, Multiple Sclerosis (MS), Generics Drugs, Pharmacy & Distribution, Diseases & Conditions, Infectious Diseases, Oncology/Hematology
| Microbiome Global Market Report 2021: COVID 19 Growth And Change to 2030Including: 1) By Type: Fecal Microbiota Transplantation (FMT); Microbiome drugs2) By Application: Inflammatory Bowel Disease; Diabetes; Multiple Sclerosis; Rheumatoid Arthritis; Other
Topics: Genomics, Proteomics, Genetic Engineering, Arthritis, Diabetes, Multiple Sclerosis (MS), COVID-19/Coronavirus, Blood Supply, Tissue Banking, Transplantation, Diabetes, Drug Discovery, Rheumatology/Arthritis
Regions: Global
| Global Non-oncology Biopharmaceuticals Market - 2021-2028
Topics: Biologics, Multiple Sclerosis (MS), Biopharmacology, Biopharmaceuticals, Oncology/Hematology, Rheumatology/Arthritis
Regions: Global
| Primary Progressive Multiple Sclerosis (PPMS) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Multiple Sclerosis (MS), Drug Discovery
| Relapsing Multiple Sclerosis (RMS) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Multiple Sclerosis (MS), Drug Discovery
| Multiple sclerosis - Pipeline Insight, 2022
Topics: Multiple Sclerosis (MS), Drug Discovery, Clinical Trial
| South and Central America Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hosp
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Central America
| Multiple Sclerosis Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Prescription Drugs, Drug Discovery
Regions: Global
| Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmacies, Retail Phar
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Global
| Digital Health in Neurology - Thematic Research
Topics: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), Telemedicine, EMR (Electronic Medical Record), CNS/Neurology
| The 2023-2028 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
Topics: Research & Development, Multiple Sclerosis (MS)
Regions: Global
| The 2023-2028 World Outlook for Multiple Sclerosis Drugs
Topics: Multiple Sclerosis (MS), Drug Discovery
Regions: Global
| Global Johnson Neuroectodermal Syndrome Market Size study, by Drug Class (Immunomodulators, Interferons, Decarboxylase Inhibitors, Dopamine Agonists and Others) by Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Mu
Topics: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), Pharmacy & Distribution, Drug Stores, CNS/Neurology
Regions: Global
| Targeted Therapeutics Market (Type: Monoclonal Antibodies and Small Molecule; Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Multiple Sclerosis, Renal Cancer, Wet Age-related Macular Degeneration, and Others; and Distribut
Topics: Antibody Technologies, Drug Development, Cancer Treatment, Multiple Sclerosis (MS), Hospitals & Clinics, Drug Discovery, Drug Stores, Oncology/Hematology
Regions: Global
| Global Interferons Market Product Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), Regional Forecasts 2021-2027
Topics: Research & Development, Hepatitis, Cancer Treatment, Multiple Sclerosis (MS), Microbiology & Virology, Oncology/Hematology
Regions: Global
| Global Neurorehabilitation Market Size study, by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), by Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cere
Topics: Parkinson's Disease, Multiple Sclerosis (MS), Hospitals & Clinics, Neurology Devices, CNS/Neurology
Regions: Global
| North America and South & Central America Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and
Topics: Pain, Alzheimer's Disease, Cancer Treatment, Mental Health, Multiple Sclerosis (MS), COVID-19/Coronavirus, Alternative & Complementary Medicine, General Pharmaceuticals, Pharmacy & Distribution, Research & Development, Drug Stores, Behavioral Health
Regions: North America
| Auto-injectors Market, by Product Type (Prefilled Auto-injectors, Fillable Auto-injectors), by Disease Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others (Diabetes, Psoriasis, etc.)), by Distribution Channel (Hospital Pharmacies, Re
Topics: Diabetes, Multiple Sclerosis (MS), Psoriasis, Hospitals & Clinics, Diabetes, Needles, Syringes, IV Access, Drug Stores, Rheumatology/Arthritis
Regions: Africa, Asia, Europe, Middle East, North America, Oceania, South America
| Chronic Progressive Multiple Sclerosis - Epidemiology Forecast to 2032
Topics: Multiple Sclerosis (MS)
| Central Nervous System Disorders Therapeutics Market, by Disease Type (Neurodegenerative Disorders {Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Others}, Infectious Diseases, Psychotic Disorders, Anxiety Disorders, Trauma, Mood Disord
Topics: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis (MS), Drug Discovery, Drug Stores, CNS/Neurology
Regions: Africa, Asia, Europe, Middle East, North America
| Autoimmune Disease Diagnostics Market Size By Disease Type (Systemic Autoimmune Disease {Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Psoriasis, Multiple Sclerosis}, Localized Autoimmune Disease {Inflammatory Bowel Disease, Type 1 Diabetes, T
Topics: Antibody Technologies, Diabetes, Autoimmune, Multiple Sclerosis (MS), Psoriasis, COVID-19/Coronavirus, Hospitals & Clinics
| Multiple Sclerosis - Global Clinical Trials Review, H2, 2021
Topics: Multiple Sclerosis (MS), Clinical Trial
Regions: Global
| Relapsing Remitting Multiple Sclerosis- Pipeline Insight, 2022
Topics: Multiple Sclerosis (MS), Drug Discovery
| Chronic Progressive Multiple Sclerosis - Market Insight, Epidemiology and Market Forecast -2032
Topics: Multiple Sclerosis (MS)
| Asia Pacific Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class (Immunosuppressant and Immunomodulators), Route of Administration (Injectable and Oral), and Distribution Channel (Hospital Pharmaci
Topics: Multiple Sclerosis (MS), COVID-19/Coronavirus, Hospitals & Clinics, Needles, Syringes, IV Access, Pharmacy & Distribution, Drug Discovery, Drug Stores
Regions: Asia, Oceania
|
Prev | 1 | 2 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
